Regulatory Governance


Viewing related articles

Bringing BioPhorum’s unique perspective to continuous manufacturing in biologics

Feb 2022 | ,

Continuous manufacturing (CM) has been a goal for the pharmaceutical industry for several years. While small molecule drug substances and drug products have achieved this in many cases, biologics are behind the global implementation of CM because of their more complex manufacturing processes.  However, the regulatory agency members of the International Committee for Harmonization (ICH) now have enough experience in the registration,...

read more

Industry feedback on ICH harmonized guideline: Continuous manufacturing of drug substances and drug products Q13 draft version

Feb 2022 | , , , ,

A comprehensive response to ICH Continuous manufacturing of drug substances and drug products Q13 draft version. The BioPhorum team overall think the draft reads well and believes the concepts and ideas are aligned with BioPhorum thinking on continuous manufacturing for biologic drug substance and drug product.

read more

The Power of Industry Collaboration: Driving Harmonization of Regulatory Requirements

Mar 2021 | , , , , , , , , , ,

Driving the harmonization of regulatory requirements – one country at a time  Regulations play a significant role in assessing marketing authorizations for drug products that are submitted for approval. Yet, regulatory agencies often differ in their degrees of harmonization. This has created an environment of divergence, in which countries each have unique standards, requirements, submissions and review processes.  The potential...

read more

Russian release – how to manage the risks of new analytical testing in Russia

Mar 2020 | , ,

The Russian Federal Service for Surveillance in Healthcare currently mandates in-country testing for all batches of biologicals imported into its market. However, later this year, a new regulation will change the testing regimen. This will move from testing all batches (although only tests that are deemed ‘simple’) to testing the first batches of biological products that are imported and then on an annual basis – but performing all tests in the...

read more

Follow BioPhorum

Search BioPhorum

Phorums

Resources